NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
641 Umeå |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 57 | 0.4% | . | . | . | . | 1 | 0.0% | . | . | . | . | 1 | 0.0% | 12609 | 99.5% | 12668 | 100.0% |
ASCUS | 134 | 14.6% | 46 | 5.0% | 3 | 0.3% | 32 | 3.5% | 1 | 0.1% | . | . | 8 | 0.9% | 696 | 75.7% | 920 | 100.0% |
CIN1 | 58 | 19.5% | 60 | 20.2% | . | . | 49 | 16.5% | . | . | . | . | 10 | 3.4% | 120 | 40.4% | 297 | 100.0% |
Atypical glandular cells/AGC | 6 | 40.0% | 4 | 26.7% | . | . | 2 | 13.3% | . | . | . | . | . | . | 3 | 20.0% | 15 | 100.0% |
Unclear atypia | 12 | 63.2% | 2 | 10.5% | . | . | . | . | . | . | . | . | 1 | 5.3% | 4 | 21.1% | 19 | 100.0% |
ASC-H | 10 | 25.0% | 6 | 15.0% | . | . | 21 | 52.5% | . | . | 1 | 2.5% | 2 | 5.0% | . | . | 40 | 100.0% |
CIN2 | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
CIN3 | 3 | 3.5% | 7 | 8.1% | 2 | 2.3% | 62 | 72.1% | 2 | 2.3% | 2 | 2.3% | 1 | 1.2% | 7 | 8.1% | 86 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Total | 280 | 2.0% | 125 | 0.9% | 5 | 0.0% | 169 | 1.2% | 3 | 0.0% | 4 | 0.0% | 23 | 0.2% | 13439 | 95.7% | 14048 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81401, M81403 |